Company intelligence / Profile preview

SciSciE Pharma

Ownership: Private
Development stage: Other

Overview

SciSciE Pharma is an early-stage biotechnology company focused on the discovery and development of novel small molecule therapeutics. The company primarily targets high-impact areas such as oncology and metabolic disorders, leveraging internal research to identify unique biological pathways. Currently, SciSciE Pharma is in the pre-clinical phase, working to advance its lead candidates toward IND-enabling studies. The firm aims to address significant unmet medical needs through precision medicine and innovative drug design strategies.

Therapeutic areas: OncologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on SciSciE Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SciSciE Pharma.

Explore the full profile